Merck KGaA Logo

Merck KGaA

6MK | F

Overview

Corporate Details

ISIN(s):
DE0006599905 (+71 more)
LEI:
4YV9Y5M8S0BRK1RP0397
Country:
United States of America
Address:
126 East Lincoln Avenue, 07065-1310 Rahway
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

The Merck Group, branded and commonly known as Merck, is a German multinational science and technology company headquartered in Darmstadt. The group includes around 250 companies; the main company is Merck KGaA in Germany. The company is divided into three business lines: Healthcare, Life Sciences and Electronics. Merck was founded in 1668 and is the world's oldest operating chemical and pharmaceutical company, as well as one of the largest pharmaceutical companies in the world. Merck operates in Europe, Africa, Asia, Oceania and the Americas. It has major research and development centres in Darmstadt, Boston, Tokyo and Beijing, as well as other Research and Development units in Taiwan, France, Israel, South Korea, India and in the UK. Merck pioneered the commercial manufacture of morphine in the 19th century and for a time held a virtual monopoly on cocaine.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Merck KGaA. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-13 17:39
Declaration of Voting Results & Voting Rights Announcements
English 81.2 KB
2025-08-05 23:02
Declaration of Voting Results & Voting Rights Announcements
English 81.2 KB
2025-07-14 15:01
Declaration of Voting Results & Voting Rights Announcements
English 81.2 KB
2025-07-08 18:21
Declaration of Voting Results & Voting Rights Announcements
English 81.2 KB
2025-07-07 11:28
Declaration of Voting Results & Voting Rights Announcements
English 81.2 KB
2025-07-04 13:25
Declaration of Voting Results & Voting Rights Announcements
English 81.3 KB
2025-07-03 10:58
Declaration of Voting Results & Voting Rights Announcements
English 75.7 KB
2025-06-13 15:37
Major Shareholding Notification
English 12.2 KB
2025-06-13 13:23
Declaration of Voting Results & Voting Rights Announcements
English 13.3 KB
2025-06-10 10:31
Declaration of Voting Results & Voting Rights Announcements
English 78.1 KB
2025-06-05 08:43
Declaration of Voting Results & Voting Rights Announcements
English 13.4 KB
2025-05-19 00:00
Quarterly Report
Q1 statement / Q1 financial report 2025
English 809.0 KB
2025-05-06 13:33
Declaration of Voting Results & Voting Rights Announcements
German 20.8 KB
2025-04-26 14:13
Declaration of Voting Results & Voting Rights Announcements
German 20.8 KB
2025-04-24 22:45
M&A Activity
Merck KGaA: Merck confirms late-stage discussions with SpringWorks Therapeutics…
English 5.3 KB

Automate Your Workflow. Get a real-time feed of all Merck KGaA filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Merck KGaA via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
NextGen Biomed Ltd. Logo
R&D of biotech medical devices for diabetes care and topical skin treatments.
Israel NXGN
NFL Biosciences Logo
Develops botanical drug candidates to treat smoking and alcohol addictions for pharma licensing.
France ALNFL
Nicox S.A. Logo
Developing innovative ophthalmology drugs for glaucoma and ocular hypertension.
France COX
Nortem BioGroup Logo
Biotech R&D of natural products for consumer health, home, and animal nutrition.
Spain MLBIO
NRGene Technologies Ltd. Logo
AI genomics software accelerating plant & animal breeding for the agriculture industry.
Israel NRGN
NUFORMIX PLC Logo
A pharma firm repurposing drugs for fibrosis and oncology via proprietary cocrystal technology.
United Kingdom NFX
Nykode Therapeutics ASA Logo
Developing targeted immunotherapies and vaccines for cancer and infectious diseases.
Norway NYKD
Oculis Holding AG Logo
Clinical-stage biopharma developing non-invasive drugs for sight-threatening eye diseases.
Switzerland OCS
ONCIMMUNE HOLDINGS PLC Logo
Antibody biomarker discovery platform for pharma and biotech partners in oncology and autoimmune disease.
United Kingdom ONC
ONCODESIGN Logo
Develops precision cancer therapies and diagnostics targeting resistance and metastasis.
France ALONC